• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sernova, AstraZeneca collaborate to deliver therapeutic cells with Sernova Cell Pouch

May 3, 2023 By Sean Whooley

Sernova Cell Pouch System Type 1 Diabetes
[Image from Sernova]
Sernova announced today that it entered into a preclinical research collaboration on drug delivery with AstraZeneca.

The collaboration aims to evaluate the use of Sernova’s Cell Pouch System in combination with AstraZeneca’s novel therapeutic cells.

London, Ontario-based Sernova designed its proprietary Cell Pouch System as an implantable and scalable medical device. It forms a natural environment in the body for the long-term survival and function of therapeutic cells. Those cells release necessary proteins or factors missing from the body to treat chronic diseases, including insulin-dependent diabetes.

Sernova’s ongoing Phase 1/2 clinical trial evaluates six patients with long-standing, insulin-dependent T1D. Those patients have hypoglycemia unawareness prior to treatment. Sernova announced positive data from that trial in June 2022, which includes three patients achieving insulin independence.

Late last year, the company received approval to proceed with a strategically optimized protocol reducing the time required for patient treatment. It also accelerates potential secondary endpoint efficacy achievement with more optimal dosing.

Read more about Sernova’s goals in this interview with the company’s CEO.

About Sernova and its agreement with AstraZeneca

AstraZeneca aims to use the Sernova Cell Pouch System as a potential platform for integration with its cell therapies. These innovative therapies cover various indications.

Under the terms of the agreement, AstraZeneca will lead and completely fund development of the cell technologies and pre-clinical activities in conjunction with Sernova. Preclinical outcomes may determine the feasibility of potential therapeutic applications. If feasible, it could lead to subsequent product development activities between the two companies.

“Sernova has developed a novel cell therapy approach for the potential treatment of insulin-dependent diabetes, hypothyroidism and hemophilia A,” said Dr. Philip Toleikis, president and CEO of Sernova. “By engrafting functional therapeutic cells within an implanted Cell Pouch, which naturally vascularizes with surrounding tissues, we create an environment for the production and release of absent or under-expressed hormones and proteins.

“We are pleased to be working with AstraZeneca in the preclinical assessment of its various proprietary therapeutic cells in combination with our Cell Pouch.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Preclinical Trials, Stem Cells Tagged With: AstraZeneca plc, Sernova Inc

IN CASE YOU MISSED IT

  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China
  • Convatec wins FDA approval for Parkinson’s treatment infusion tech

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS